Results 151 to 160 of about 38,790 (260)

Lutetium-177 Radiolabeled Gold Nanoparticles for Prostate Cancer Theranostics. [PDF]

Nanomaterials (Basel)
Apostolopoulou A, Salvanou EA, Liolios C, Xanthopoulos S, Koźmiński P, Bouziotis P.   +5 more
europepmc   +1 more source

Rhenium-186-labeled <i>ortho</i>-hydroxythiobenzhydrazide: a potential theranostic agent for use in metastatic breast cancer. [PDF]

RSC Adv
Mitra A, Chakraborty A, Upadhye T, Sahu S, Tawate M, Chakraborty S, Chakravarty R, Vimalnath KV, Kar S, Sengupta D, Gangopadhyay S, Goswami S, Gangopadhyay PK, Banerjee S.   +13 more
europepmc   +1 more source

Evaluation of 64Cu-based radiopharmaceuticals that target Aβ peptide aggregates as diagnostic tools for Alzheimer’s disease [PDF]

, 2017
Bandara, Nilantha, Han, Byung Hee, Krieger, Stephanie, Mirica, Liviu M, Rogers, Buck E, Schultz, Jason W, Sharma, Anuj K   +6 more
core   +2 more sources

Radioiodination of Two Carborane‐Based Dual Cyclooxygenase‐2/5‐Lipoxygenase Inhibitors and Their In Vitro and In Vivo Evaluation

ChemBioChem, Volume 27, Issue 7, 14 April 2026.
Two dicarbadodecaborane(12)‐based dual cyclooxygenase‐2/5‐lipoxygenase (COX‐2/5‐LO) inhibitors were 123I‐labeled. Refinement of labeling and formulation conditions and extensive in vitro characterization are presented. Cell uptake studies in COX‐2‐ and 5‐LO‐overexpressing cell lines showed COX‐2‐independent and partly 5‐LO‐dependent uptake.
Jonas Schädlich, Martin Ullrich, Cathleen Haase‐Kohn, Robert Wodtke, Sebastian Braun, Maximilian Molitor, Bettina Hofmann, Dieter Steinhilber, Klaus Kopka, Evamarie Hey‐Hawkins, Jens Pietzsch, Markus Laube   +11 more
wiley   +1 more source

Modulating IDO1 and TDO Inhibition Through Structural Modification of Diaryl Hydroxylamines

ChemMedChem, Volume 21, Issue 7, 14 April 2026.
Diaryl hydroxylamines have emerged as promising scaffolds for targeting the tryptophan‐catabolizing enzymes indoleamine 2,3‐dioxygenase 1 (IDO1) and tryptophan 2,3‐dioxygenase (TDO), key drivers of tumor immune escape. Building on the reported dual IDO1/TDO inhibitory activity of O‐((3,5‐difluorophenyl)(phenyl)methyl)hydroxylamine, a series of diaryl ...
Angeliki S. Foscolos, Alexandros Pappas, Christos N. Petroulias, Anna Kapella, Georgia M. Prifti, Grigoris Zoidis, Minas Papadopoulos, Anastasia Mpakali, Aristeidis Chiotellis   +8 more
wiley   +1 more source

Radiolabeled Iron-Based Nanomaterials for Cancer Diagnosis and Therapy. [PDF]

Int J Nanomedicine
Ma YX, Dai KL, Sun N, Zhang S.
europepmc   +1 more source

Sex Differences in [ 68Ga]Ga‐NODAGA‐Exendin‐4 Uptake in the Pituitary of Individuals With Type 2 Diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4387-4390, May 2026.
Sevilay Tokgöz, Marti Boss, Rick I. Meijer, Theodorus J. P. Jansen, Laura N. Deden, Cees J. Tack, Bastiaan E. de Galan, Martin Gotthardt   +7 more
wiley   +1 more source

Streamlined Radiosynthesis of [¹⁸F]Fluproxadine (AF78): An Unprotected Guanidine Precursor Enables Efficient One-Step, Automation-Ready Labeling for Clinical Use. [PDF]

Pharmaceutics
Chen X, Ohta K, Kimura H, Yagi Y, Sasaki T, Nose N, Akehi M, Yamane T, Werner RA, Higuchi T.   +9 more
europepmc   +1 more source

Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: Feasibility of an antibody-based companion diagnostic agent [PDF]

, 2017
Dehdashti, Farrokh, Hawthorne, Thomas, Hoog, Jeremy, Hyrc, Krzysztof, Keler, Tibor, Laforest, Richard, Lapi, Suzanne E, Lee, Supum, Li, Shunqiang, Ma, Cynthia X, Marquez-Nostra, Bernadette V, Nie, Xingyu, Vitale, Laura   +12 more
core   +2 more sources

Challenging the Macrocycle Paradigm: Four-Arm, High-Denticity Acyclic Chelators for Radiopharmaceuticals Incorporating Actinium and Lanthanides. [PDF]

Inorg Chem
Fernández-Pavón D, de Blas A, Martínez-Cabanas M, Barriada JL, Patrick BO, Orvig C, Bénard F, Yang H, Wharton L, Jaraquemada-Peláez MG, Rodríguez-Blas T.   +10 more
europepmc   +1 more source